Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients

The DecisionDx-Melanoma test provides prognostic information for patients with cutaneous melanoma (CM). Using formalin-fixed paraffin-embedded primary tumor tissue, the RT-PCR-based test classifies patients into a low- (Class 1) or high-risk (Class 2) category for recurrence based on expression of 3...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Robert W. Cook, Brooke Middlebrook, Jeff Wilkinson, Kyle R. Covington, Kristen M. Oelschlager, Federico A. Monzon, John F. Stone
Format: Artigo
Idioma:anglès
Publicat: 2018
Accés en línia:https://doi.org/10.1186/s13000-018-0690-3
https://diagnosticpathology.biomedcentral.com/track/pdf/10.1186/s13000-018-0690-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!